Pyroptosis, a form of programmed cell death (PCD), has garnered increasing attention as it relates to innate immunity and diseases. However, the involvement of pyroptosis in the mechanism by which lobaplatin acts against colorectal cancer (CRC) is unclear. Our study revealed that treatment with lobaplatin reduced the viability of HT-29 and HCT116 cells in a dose-dependent manner. Morphologically, HT-29 and HCT116 cells treated with lobaplatin exhibited microscopic features of cell swelling and large bubbles emerging from the plasma membrane, and transmission electron microscopy (TEM) revealed multiple pores in the membrane. GSDME, rather than GSDMD, was cleaved in lobaplatin-induced pyroptosis in HT-29 and HCT116 cells due to caspase-3 activation. Knocking out GSDME switched lobaplatin-induced cell death from pyroptosis to apoptosis but did not affect lobaplatin-mediated inhibition of growth and tumour formation of HT-29 and HCT116 cells in vivo and in vitro. Further investigation indicates that lobaplatin induced reactive oxygen species (ROS) elevation and JNK phosphorylation. NAC, a ROS scavenger, completely reversed the pyroptosis of lobaplatin-treated HT-29 and HCT116 and JNK phosphorylation. Activated JNK recruited Bax to mitochondria, and thereby stimulated cytochrome c release to cytosol, followed by caspase-3/-9 cleavage and pyroptosis induction. Therefore, in colon cancer cells, GSDME mediates lobaplatin-induced pyroptosis downstream of the ROS/JNK/Bax-mitochondrial apoptotic pathway and caspase-3/-9 activation. Our study indicated that GSDME-dependent pyroptosis is an unrecognized mechanism by which lobaplatin eradicates neoplastic cells, which may have important implications for the clinical application of anticancer therapeutics.

Inflammation plays a central role in the etiology of diabetic nephropathy, a global health issue. We observed a significant reduction in the renal expression of fibroblast growth factor 1, a known mitogen and insulin sensitizer, in patients with diabetic nephropathy and in mouse models implying that fibroblast growth factor 1 possesses beneficial anti-inflammatory and renoprotective activities in vivo. To test this possibility, we investigated the effects of chronic intraperitoneal administration of fibroblast growth factor 1 into both the streptozotocin-induced type 1 diabetes and db/db type 2 diabetes models. Indeed, recombinant fibroblast growth factor 1 significantly suppressed renal inflammation (i.e., cytokines, macrophage infiltration), glomerular and tubular damage, and renal dysfunction in both type 1 and type 2 diabetes mice. Fibroblast growth factor 1 was able to correct the elevated blood glucose levels in type 2 but not in type 1 diabetic mice, suggesting that the anti-inflammatory effect of fibroblast growth factor 1 was independent of its glucose-lowering activity. The mechanistic study demonstrated that fibroblast growth factor 1–mediated inhibition of the renal inflammation in vivo was accompanied by attenuation of the nuclear factor κB and c-Jun N-terminal kinase signaling pathways, further validated in vitro using cultured glomerular mesangial cells and podocytes. Thus, fibroblast growth factor 1 holds great promise for developing new treatments for diabetic nephropathy through countering inflammatory signaling cascades in injured renal tissue.

An unprecedented {Gd18} nanowheel was solvothermally synthesized with a novel diacylhydrazone ligand. It features a rare single-stranded skeleton just like a Reuleaux triangle with vertices buckled in, represents the highest nuclearity and largest size in lanthanide (Ln) wheels reported so far, and shows a large magnetocaloric effect (MCE).

Tin sulfide (SnS) is attracted much attentions as anode material for sodium ion batteries (SIBs), because of its have various advantages including high capacity and unique 2D structure. However, the...

The organic ligands 5,7-dibromo-2-methyl-8-quinolinol (L1), 1,10-phenanthroline (L2), and 5,7-dichloro-2-methyl-8-quinolinol (L3) were used to react with Dy(NO3)3·6H2O under solvothermal conditions at 80 °C to obtain the complexes [Dy(L1)3(H2O)] (1), [Dy(L2)2(NO3)3] (2), and [Dy(L3)3(H2O)] (3), respectively.

No abstract

To develop new lanthanide single-molecule m a g n e t s ( S M M s ) , t w o n e w c o m p l e x e s o f [Dy 2 (MeOH) 2 (HL 1 ) 2 (NO 3 ) 2 ]•2MeOH (1) and [Dy 6(2) were obtained by reacting Dy(NO) 3 •6H 2 O with 3-amino-1,2-propanediol in the presence of 2-hydroxynaphthaldehyde for 1 and by reacting DyCl 3 •6H 2 O with 1,1-di-(hydroxymethyl)ethylamine in the presence of 2-hydroxynaphthaldehyde for 2, respectively, in which the Schiff base ligands of 3-(((2-hydroxynaphthaen-1-yl)methylene)amino)propane-1,2-diol (H 3 L 1 ) and 2-(β-naphthalideneamino)-2-(hydroxylmethyl)-1-propanol (H 3 L 2 ) were in situ formed. The two Dy(III) ions in 1 are linked by two O alkoxy atoms of two (HL 1 ) 2− ligands to build a dinuclear skeleton. Complex 2 presents a nearly planar hexanuclear skeleton constructed from four edge-shared triangular Dy 3 units with the two peripheral Dy 3 units consolidated by two μ 3 -O bridges and the two central Dy 3 units consolidated by one μ 3 -O bridge. Obviously, they exhibit a different topological arrangement resulting from the linkage of the Schiff base ligands. Both of them are typical SMMs under zero dc fields, with a U eff /k B value of 34 K for 1 and 40 K for 2, respectively. Multiple processes are involved in the relaxation processes of 1 and 2. The different SMM performances of the two titled complexes reveal a tuning effect of Schiff base ligands through tuning the coordination environments and topological arrangements of dysprosium(III) ions, which is supported by the theoretical calculations.

The syntheses, structures, and characterization of four 3d-4f butterfly clusters are described. With different polyhydroxy Schiff-base ligands 2-(((2-hydroxy-3-methoxyphenyl)methylene)amino)-2-(hydroxymethyl)-1,3-propanediol (H4L1) and 2-(2,3-dihydroxpropyliminomethyl)-6-methoxyphenol (H3L2), three heterotetranuclear NiLn complexes (NiDy-L1 (1), NiTb-L2 (2), NiDy-L2 (3)) and one heterohexanuclear CoDy complex (4) were obtained. The three heterotetranuclear NiLn complexes display a central planar butterfly topology. The heterohexanuclear complex was built from butterfly CoDy clusters and two Dy(III) ions by the bridging of pivalate. The vertices of the body positions of the butterfly are occupied by transition metal ions in all four complexes. Magnetic analyses indicate that the complexes exhibit typical single-molecule magnet behaviour with anisotropy barriers of 33.7 cm(-1), 60.3 cm(-1), 39.6 cm(-1), and 18.4 cm(-1) for 1-4, respectively. Ab initio calculations were performed on these complexes, and the low lying electronic structure of each Ln(III) (Ln = Dy, Tb) ion and the magnetic interactions were determined. It was found that the two Ln ions may have much more contribution to the total relaxation barrier through the stronger 3d-4f exchange couplings compared to weak Ln-Ln interactions.